缺血性卒中血清叶酸水平与早期神经功能恶化的相关性研究

doi:10.3969/j.issn.1673-5765.2020.05.012

摘要/Abstract

摘要：

目的探讨缺血性卒中患者基线血清叶酸水平与早期神经功能恶化（early neurological deterioration， END）的关系。方法回顾性分析2018年1月1日-9月30日于北京市海淀医院（北京大学第三医院海淀院区）神经内科住院的发病48 h内的缺血性卒中患者的临床资料。根据是否在入院7 d内发生END，将患者分为END 组和非END组，对比分析两组患者的基线资料。采用单因素和多因素逻辑回归分析缺血性卒中患者 END的独立影响因素。结果本研究共纳入304例患者，男性209例（68.8%），平均年龄67.2±13.9岁，血清叶酸水平为 15.4（11.3～21.9）nmol/L。其中END组患者42例（13.8%），非END组患者262例（86.2%）。与非END组相比，END组患者具有更高的年龄（P =0.008）、糖尿病史（P =0.002）、基线NIHSS评分（P =0.022）和更低的基线叶酸水平（P =0.030），差异具有统计学意义。回归分析结果显示，年龄（每增长1岁：OR 1.033， 95%CI 1.001～1.066，P =0.041）和糖尿病史（OR 2.724，95%CI 1.339～5.539，P =0.006）是END的独立危险因素；基线较高的血清叶酸水平（OR 0.463，95%CI 0.225～0.952，P =0.036）是END的独立保护因素。结论年龄增加和糖尿病史是END的独立危险因素，基线较高的血清叶酸水平是END的独立保护因素。

文章导读： 缺血性卒中患者的基线血清叶酸水平较高是早期神经功能恶化的独立保护因素，可为临床探索新的急性缺血性卒中治疗策略提供一定的参考依据。

关键词: 叶酸; 缺血性卒中; 早期神经功能恶化

Abstract:

Objective To explore the association between the level of serum folate and early neurological deterioration (END) in ischemic stroke patients. Methods Clinical data of ischemic stroke patients within 48 hours from onset who admitted to Beijing Haidian Hospital from January 1, 2018 to September 30, 2018 were retrospectively analyzed. According to whether END occurred within 7 days or not, all the patients were divided into END group and non-END group. Univariate and multivariate binary logistic analysis was performed to analyze the relationship between serum folate level and END. Results A total of 304 patients were enrolled, with an average age of 67.2±13.9 years old and 209 males (68.8%). The average level of baseline serum folate was 15.4 (11.3-21.9) nmol/L. Of all patients, 42 (13.8%) patients worsened during the 7 days after admission. Compared with non-END group, END group had higher age and baseline NIHSS score, higher percentage of diabetes and lower level of folate (all P <0.05). Logistic analysis showed that age (increase per 1 year: OR 1.033, 95%CI 1.001- 1.066, P =0.041) and history of diabetes (OR 2.724, 95%CI 1.339-5.539, P =0.006) were independent risk factors for END, and high level of serum folate (OR 0.463, 95%CI 0.225-0.952, P =0.036) was an independent protective factor for END.

Conclusions Advanced age and history of diabetes were independent risk factors for END. High serum folate level was independent protective factor for END in ischemic stroke patients.

Key words: Folate; Ischemic Stroke; Early neurological deterioration

刘伟，冯浩，刘磊，冯研，史冬梅，于逢春. 缺血性卒中血清叶酸水平与早期神经功能恶化的相关性研究[J]. 中国卒中杂志, 2020, 15(05): 527-531.

LIU Wei,FENG Hao, LIU Lei, FENG Yan, SHI Dong-Mei, YU Feng-Chun. Correlation between Serum Folate Level and Early Neurological Deterioration in Ischemic Stroke[J]. Chinese Journal of Stroke, 2020, 15(05): 527-531.

参考文献

[1] GBD 2017 Causes of Death Collaborators. Global，

regional，and national age-sex-specific mortality for

282 causes of death in 195 countries and territories，

1980-2017：a systematic analysis for the Global

Burden of Disease Study 2017[J]. Lancet，2018，392

（10159）：1736-1788.

[2] CRIDER K S，ZHU J H，HAO L，et al. Mthfr

677C->T genotype is associated with folate

and homocysteine concentrations in a large，

population-based，double-blind trial of folic acid

supplementation[J]. Am J Clin Nutr，2011，93（6）：

1365-1372.

[3] MARTIN A J，PRICE C I. A systematic review and

meta-analysis of molecular biomarkers associated

with early neurological deterioration following acute

stroke[J]. Cerebrovasc Dis，2018，46（5-6）：230-

241.

[4] GENG H H，WANG Q，LI B，et al. Early

neurological deterioration during the acute phase

as a predictor of long-term outcome after first-ever

ischemic stroke[J/OL]. Medicine，2017，96（51）：

e9068[2020-02-09]. https：//doi.org/10.1097/MD.

0000000000009068.

[5] SENERS P，TURC G，OPPENHEIM C，et al.

Incidence，causes and predictors of neurological

deterioration occurring within 24 h following

acute ischaemic stroke：a systematic review with

pathophysiological implications[J]. J Neurol

Neurosurg Psychiatry，2015，86（1）：87-94.

[6] CARBONELL T，RAMA R. Iron，oxidative stress

and early neurological deterioration in ischemic

stroke[J]. Curr Med Chem，2007，14（8）：857-874.

[7] HE K，MERCHANT A，RIMM E B，et al. Folate，

vitamin B6，and B12 intakes in relation to risk of

stroke among men[J]. Stroke，2004，35（1）：169-174.

[8] CUI S S，LV X，LI W，et al. Folic acid modulates

VPO1 DNA methylation levels and alleviates

oxidative stress-induced apoptosis in vivo and in

vitro[J]. Redox Biol，2018，19：81-91.

[9] OCTAVIA Y，KARARIGAS G，DE BOER M，

et al. Folic acid reduces doxorubicin-induced

cardiomyopathy by modulating endothelial nitric

oxide synthase[J]. J Cell Mol Med，2017，21（12）：

3277-3287.

[10] 中华医学会神经病学分会，中华医学会神经病学分

会脑血管病学组. 中国急性缺血性脑卒中诊治指南

2014[J]. 中华神经科杂志，2015，48（4）：246-257.

[11] KERR W C，STOCKWELL T. Understanding

standard drinks and drinking guidelines[J]. Drug

Alcohol Rev，2012，31（2）：200-205.

[12] FOOKS G J，SMITH J，LEE K，et al. Controlling

corporate influence in health policy making? An

assessment of the implementation of article 5. 3

of the World Health Organization framework convention on tobacco control[J]. Global Health，

2017，13（1）：12.

[13] MANCIA G，DE BACKER G，DOMINICZAK A，

et al. 2007 guidelines for the management of arterial

hypertension：the task force for the management

of arterial hypertension of the European Society of

Hypertension（ESH）and of the European Society of

Cardiology（ESC）[J]. Eur Heart J，2007，28（12）：

1462-1536.

[14] CONLIN P R，COLBURN J，ARON D，et al.

Synopsis of the 2017 U. S. Department of Veterans

Affairs/U.S. Department of Defense Clinical

Practice Guideline：management of type 2 diabetes

mellitus[J]. Ann Intern Med，2017，167（9）：655-

663.

[15] SHARMA S，SHARMA J B，YADAV M，et al.

Cross-sectional study of nutritional markers in

pregnancy[J]. IJEM，2016，20（6）：825-830.

[16] DUAN Z，GUO W，TANG T，et al. Relationship

between high-sensitivity C-reactive protein and early

neurological deterioration in stroke patients with and

without atrial fibrillation[J]. Heart Lung，2020，49

（2）：193-197.

[17] HU W，LIU D Z，LI Q，et al. Decreasing

serum 25-hydroxyvitamin D levels and risk of

early neurological deterioration in patients with

ischemic stroke[J/OL]. Brain Behav，2019，9（3）：

e01227[2020-02-09]. https：//doi.org/10.1002/brb3.

1227.

[18] SENERS P，TURC G，OPPENHEIM C，et al.

Incidence，causes and predictors of neurological

deterioration occurring within 24 h following

acute ischaemic stroke：a systematic review with

pathophysiological implications[J]. J Neurol

Neurosurg Psychiatry，2015，86（1）：87-94.

[19] TOWFIGHI A，ARSHI B，MARKOVIC D，et al.

Homocysteine-lowering therapy and risk of recurrent

stroke，myocardial infarction and death：the impact

of age in the VISP trial[J]. Cerebrovasc Dis，2014，37

（4）：263-267.

[20] LONN E，YUSUF S，ARNOLD M J，et al.

Homocysteine lowering with folic acid and B

vitamins in vascular disease[J]. N Engl J Med，2006，

354（15）：1567-1577.

[21] HSU C Y，CHIU S W，HONG K S，et al. Folic acid

in stroke prevention in countries without mandatory

folic acid food fortification：a meta-analysis of

randomized controlled trials[J]. J Stroke，2018，20

（1）：99-109.

[22] SPENCE J D，YI Q，HANKEY G J. B vitamins

in stroke prevention：time to reconsider[J]. Lancet

Neurol，2017，16（9）：750-760.

[23] YUYUN M F，NG L L，NG G A. Endothelial

dysfunction，endothelial nitric oxide bioavailability，

tetrahydrobiopterin，and 5-methyltetrahydrofolate

in cardiovascular disease. Where are we with

therapy?[J]. Microvasc Res，2018，119：7-12.

[24] CUI S S，LV X，LI W，et al. Folic acid modulates

VPO1 DNA methylation levels and alleviates

oxidative stress-induced apoptosis in vivo and in

vitro[J]. Redox Biol，2018，19：81-91.

[25] MÜNZEL T，DAIBER A. Role of endothelial and

macrophage tetrahydrobiopterin in development

and progression of atherosclerosis：BH4 puzzle

solved?[J]. Cardiovasc Res，2018，114（10）：1310-

1312.

[26] ANTONIADES C，SHIRODARIA C，WARRICK

N，et al. 5-methyltetrahydrofolate rapidly improves

endothelial function and decreases superoxide

production in human vessels：effects on vascular

tetrahydrobiopterin availability and endothelial

nitric oxide synthase coupling[J]. Circulation，2006，

114（11）：1193-1201.